百时美施贵宝否认沙格列汀会导致心血管疾病风险增加,并且称沙格列汀非常安全。[來源請求] Augeri D; et al. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally
6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis. J. Med. Chem. 2017, 60, 10, 4212–4233